ABSTRACT. A six-year-old spayed Pug was presented with crust formation and ulcer on the skin. The patient had recieved long-term glucocorticoid therapy for treatment of tentatively diagnosed panniculitis. Severe calcification and pyoderma was observed and the patient was diagnosed with iatrogenic Cushing's syndrome and predonisolone was gradually withdrawn. After the withdrawal, the patient d eveloped marked hypercalcemia (15.3 mg/dl) and finally died from renal failure. It is postulated that the eluted calcium from the calcified lesions may have contributed to the high serum calcium level as the underlying disease was not identified on necropsy. KEY WORDS: calcinosis cutis, hypercalcemia, iatrogenic Cushing's syndrome.
Calcinosis cutis is a condition characterized by the deposition of crystals of calcium phosphate in the skin. Calcinosis cutis is classically classified into three categories: metastatic, dystrophic and idiopathic. Metastatic calcification is associated with chronic renal disease that results in the abnormal metabolism of calcium and phosphorus, but it is rarely seen in dogs. There are some reports of dystrophic calcification occurring in injured, degenerated, or dead tissue, and the calcification is classified into two types. Localized calcinosis cutis is termed calcinosis circumscripta in dogs, occurs in inflammatory skin lesions (tuberculosis, foreign body granuloma, demodicosis, staphylococcal pododermatitis), degenerative skin lesions (follicular cyst), and in neoplastic lesions (pilomatrixoma). Extensive calcinosis cutis is termed calcinosis universalis. Calcinosis universalis occurs in the skin of the patients with Cushing's syndrome, diabetes mellitus or percutaneous penetration [7] and has been frequently reported in dogs with naturally occurring or iatrogenic Cushing's syndrome [6, 7] . The treatment of Cushing's syndrome usually results in regression of the skin lesion both clinically and histopathologically [3] . Hypercalcemia usually develops as a result of increased calcium resorption from bone or kidney, or of increased calcium absorption from the gastrointestinal tract. The common causes of hypercalcemia are tumors, hyperadrenocorticism, chronic renal failure and primary hyperparathyroidism [5] . We encountered a patient with hypercalcemia after the resolution of cutaneous calcification with iatrogenic Cushing's syndrome.
A 6-year-old spayed pug was presented with crust formation and ulcer on the neck, shoulder and left carpal skin. The owner explained that the lesions originated in an induration at the site of a vaccination six months before presentation. A diagnosis of sterile nodular panniculitis was made by the referred veterinarian and treated with a high dose of predonisolone (0.5-4.0 mg/kg) for six months.
On physical examination, skin of neck, axilla and shoulder exhibited the thickness and ulcer with erythema. Biopsy of the shoulder skin and histopathological examination revealed acanthosis and intercellular edema in epidermis, dilatation of capillary vessels and infiltration of mononuclear cells in the upper dermis, and extensive calcification in upper and middle dermis. Calcium deposits were confirmed by a positive reaction to von Kossa staining. Complete blood counts and blood chemical examination revealed neutrophilia with left shift, high ALP, ALT, cholesterol levels, and the absence of a response to adrenocorticotropic hormone (ACTH) stimulation test ( Table 1 ). The patient was diagnosed with iatrogenic Cushing's syndrome. The serum calcium concentration was then within the normal range (8.7 mg/dl).
In spite of the decreased dose of predonislone, severe deep pyoderma on shoulder progressed extensively as a mass (Fig. 1) During the two-month withdrawal period, the patient developed hypercalcemia, hyperphosphatamia and renal failure ( Table 1 ). The patient was hospitalized and predonisolone was completely withdrawn with supportive therapy. Seven days after complete withdrawal, the patient was responded normally to the ACTH stimulation test, but the serum calcium level remained high (16.0 mg/dl). Since the patient had been given the normal canned commercial food without vitamin D supplement, hyperparathyroidism or malignancy-related hypercalcemia was suspected to be a cause of hypercalcemia. The level of parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTH-rp) were measured in a commercial laboratory (Mitsubishi Kagaku Bio-Clinical Laboratories, Tokyo, Japan) with radio-immuno assay. The PTH and PTH-rp level was 10 pg/ml (reference range: 36-66 pg/ml) and less than 1.1 pmol/l (reference range: < 1.4 pmol/l), respectively, indicating that these values were within the normal range.
Despite fluid therapy with furosemide and oral silicate alminium administered, the patient showed little response. Therefore, calcitonin salmon (Calcitoran, Teikoku Hormone, Tokyo, Japan) was injected intramuscularly (2 U/kg) once a day. The serum calcium level was decreased from 15.4 mg/dl to 13.4 mg/dl by the calcitonin salmon injection. By increasing the dose of calcitonin salmon to 4 U/kg/day, the serum calcium level was reduced to the normal range (11.1 mg/dl), but it returned to the high level (14.1 mg/dl) within three days. Severe deep pyoderma and renal failure (BUN 52.3 mg/dl, Creatinine 3.1 mg/dl) developed in spite of the administration of antibiotics and calcitonin salmon. The patient expired five days after discharge from the hospital as requested by the owner. Necropsy revealed atrophy of the parathyroid gland and no neoplastic lesions were found either macro-or micro-scopically. Disseminated calcification in the skin (Fig. 2) , large intestine, stomach and kidneys were found. The kidneys were gritty and calcification of all tissue, including tubular epithelium and glomerulus with mild interstitial nephritis was observed microscopically. We suspected that severe calcification as well as a sustained high serum calcium level reduced renal function and eventually killed the patient.
Cutaneous calcification is observed in up to 33% of patients with spontaneous and iatrogenic hyperadrenocorticism [1, 6] . Dermatohistopathology of the calcified lesions in our patient revealed severe calcium deposits in superficial and deep dermis as confirmed by the Von Kossa stain, whereas inflammatory cell infiltrations in dermis was minimum to moderate implying that deep pyoderma may have occurred secondary to foreign body reaction to the deposited calcium.
In General, hypercalcemia occurs in dogs suffering from systemic diseases including neoplasia, Addison's disease, renal failure and hyperparathyroidism [5] . As our patient had already had cutaneous calcification before developing renal failure, it is considered that the renal failure may not be the cause of the cutaneous calcification. Dogs with malignances, especially with lymphoma, frequently exhibited a high serum calcium level through the PTH-rp, which has an effect similar to that of PTH [5] . In our patient, however, the PTH-rp level was within the normal range. The adrenal glands were atrophied on autopsy, even though the ACTH stimulation test after glucocorticoid withdrawal indicated normal adrenal gland function. Therefore, Addison's disease is not likely to be the cause of hypercalcemia. Hypercalcemia during the resolution of calcinosis cutis universalis was reported in human juvenile dermatomyositis patients [4, 8] . The authors speculated thar calcium might be eluted from the calcified skin into the blood stream as the underlying disease improves [4, 8] . To the best of our knowledge, there is no report of the occurrence of hypercalcemia after the improvement of cutaneous calcification in dogs, except a personal communication [2] . Hypercalcemia in our patient may have been caused by the elution of calcium from the calcinosis cutis lesions despite the high serum calcium-phosphorus product, since we could not find any other causes associated with hypercalcemia biochemically or histopathologically. The exact mechanism of the hypercalcemia in our patient is unknown, but the serum calcium level should be monitored carefully when managing patients with calcinosis universalis.
